E., Wilson, R
Since this injection is administered by a healthcare professional, the risk of overdose is low
Research overview Related protocols and comparisons BPC-157 (5 mg Vial) Dosage Protocol BPC-157 (10 mg Vial) Dosage Protocol BPC-157 + TB-500 (10 mg Blend) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol TB-500 (5 mg Vial) Dosage Protocol
22 Structure GSTs, owing to their pivotal role in xenobiotic metabolism, were among the first cytosolic proteins to have their structure elucidated, with the porcine GST Pi 1 (GSTP1) being the maiden member to be structurally characterized
What to track Body composition: Weight weekly (but not daily) Body measurements (waist, hips, thighs) Photos every 2-4 weeks Clothing fit Energy and vitality: Daily energy levels (1-10 scale) Exercise performance Recovery time Mental clarity Hormonal symptoms: Hot flash frequency Sleep quality Mood stability Libido Appearance: Skin quality and texture Hair thickness Nail strength Overall glow Bloodwork recommendations Baseline (before starting): Complete metabolic panel Lipid panel Thyroid panel (TSH, Free T3, Free T4) Estrogen, progesterone, testosterone IGF-1 Fasting glucose and insulin Follow-up (every 3-6 months): IGF-1 (monitor GH peptide effects) Metabolic panel Glucose/HbA1c Thyroid if issues Adjust based on results: IGF-1 should increase with GH peptides Glucose improving with weight loss peptides Thyroid stable or improved When to adjust doses Increase dose if: No results after 6-8 weeks at current dose Benefits plateaued Bloodwork supports (IGF-1 not elevated enough) Tolerating current dose well Decrease dose if: Side effects bothersome Results good at lower dose IGF-1 very elevated Cost concerns Stop if: Severe adverse effects No benefit after 3-6 months Pregnancy planned Health condition develops See our peptide cycle planning guide , can you cycle different peptides , and peptide dosing guide
PlexusDx's Precision Peptide Genetic Test provides context on broader metabolic and peptide pathway predispositions that can inform provider discussions
